Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
Business Wire•12/11/2026•08:30 ET
0
Key Highlights
- ➤Health Canada approves t:slim X2 compatibility with Abbott’s FreeStyle Libre 3 Plus Sensor
- ➤Health Canada expands t:slim X2 indications to type 2 diabetes and pregnancy
- ➤Canadian availability of compatibility and expanded indications expected in Q2 2027
- ➤Control-IQ+ users achieved 0.9% A1C reduction versus 0.3% for controls
- ➤Pregnancy trial showed 12.6% more time in target glucose range
Expert Statements
John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care
“These expanded indications for our Canadian customers underscore the strength of our portfolio and our commitment to bringing innovative diabetes technology to more people worldwide.”
John Sheridan, President and Chief Executive Officer of Tandem Diabetes Care
“By increasing access to our AID technology, we’re broadening our impact and advancing our mission to improve lives across the diabetes community.”
Tandem Diabetes Care Receives Multiple Health Canada Approvals for t:slim X2 Insulin Pump
Approvals include compatibility with Abbott’s FreeStyle Libre 3 Plus sensor and indications for type 2 diabetes and for pregnancy in type 1 diabetes.
Get started
Create a free account to read the full story.